LataMed AI Corp. (LMED)
OTCMKTS · Delayed Price · Currency is USD
2.455
+0.055 (2.29%)
At close: May 12, 2026
LataMed AI Statistics
Total Valuation
LataMed AI has a market cap or net worth of 137.81 million. The enterprise value is 138.21 million.
| Market Cap | 137.81M |
| Enterprise Value | 138.21M |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LataMed AI has 56.13 million shares outstanding. The number of shares has increased by 11.53% in one year.
| Current Share Class | 56.13M |
| Shares Outstanding | 56.13M |
| Shares Change (YoY) | +11.53% |
| Shares Change (QoQ) | +46.10% |
| Owned by Insiders (%) | 71.26% |
| Owned by Institutions (%) | n/a |
| Float | 16.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -218.45 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -666.10 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.82 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 1.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -69,162 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +145.50% in the last 52 weeks. The beta is -0.55, so LataMed AI's price volatility has been lower than the market average.
| Beta (5Y) | -0.55 |
| 52-Week Price Change | +145.50% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 58.42 |
| Relative Strength Index (RSI) | 58.71 |
| Average Volume (20 Days) | 118,464 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.15 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -171,852 |
| Pretax Income | -207,485 |
| Net Income | -207,485 |
| EBITDA | n/a |
| EBIT | -171,852 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 394,937 |
| Net Cash | -394,937 |
| Net Cash Per Share | -0.01 |
| Equity (Book Value) | -630,860 |
| Book Value Per Share | -0.01 |
| Working Capital | -630,860 |
Cash Flow
| Operating Cash Flow | -205,791 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 55,591 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LataMed AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.53% |
| Shareholder Yield | -11.53% |
| Earnings Yield | -0.15% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 14, 2024. It was a reverse split with a ratio of 0.0022222.
| Last Split Date | Oct 14, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0022222 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |